ListarMED_Articles por tema "overall survival"
Mostrando ítems 1-4 de 4
-
Effectiveness of Hyperthermic Intraperitoneal Chemotherapy Associated with Cytoreductive Surgery in the Treatment of Advanced Ovarian Cancer: Systematic Review and Meta-Analysis
MDPI (2023-01-30)Objective: The use of hyperthermic intraperitoneal chemotherapy (HIPEC) as a treatment for epithelial ovarian cancer remains controversial. Our study aims to analyze the overall survival and disease-free survival for the ... -
Neoadjuvant Chemotherapy plus Interval Cytoreductive Surgery with or without Hyperthermic Intraperitoneal Chemotherapy (NIHIPEC) in the Treatment of Advanced Ovarian Cancer: A Multicentric Propensity Score Study
MDPI (2023-08-26)Simple Summary Advanced ovarian cancer (Stages III-IV) continues to be one of the gynecological tumors with the highest mortality. Standard treatment consists of debulking surgery and subsequent adjuvant chemotherapy. ... -
Should We Abandon Intraperitoneal Chemotherapy in the Treatment of Advanced Ovarian Cancer? A Meta-Analysis
MDPI (2023-11-23)Background: Ovarian cancer is the gynaecological malignancy with the highest mortality and diagnosis often occurs in its advanced stages. Standard treatment in these cases is based on complete cytoreductive surgery with ... -
Surgery in Recurrent Ovarian Cancer: A Meta-Analysis
MDPI (2023-07-02)Simple Summary Ovarian cancer has the highest mortality rate of any type of gynecological cancer because it is diagnosed in advanced stages and its recurrence rate is about 80%. The standard treatment for recurrences of ...